spirobromin has been researched along with Leukemia, Erythroblastic, Acute in 1 studies
*Leukemia, Erythroblastic, Acute: A myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Evtukh, VP; Gashchuk, AP; Zverkova, AS | 1 |
1 other study(ies) available for spirobromin and Leukemia, Erythroblastic, Acute
| Article | Year |
|---|---|
[The functional activity of the natural killers during the experimental treatment of hemoblastoses].
Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Drug Evaluation, Preclinical; Killer Cells, Natural; Leukemia, Erythroblastic, Acute; Male; Neoplasm Transplantation; Rats; Rats, Inbred Strains; Spiro Compounds; Time Factors | 1990 |